Elicera Therapeutics AB
ELIC | ST
Overview
Corporate Details
- ISIN(s):
- SE0015382080 (+1 more)
- LEI:
- 549300I35L0R4INBFG27
- Country:
- Sweden
- Address:
- C/O Elicera Therapeutics AB, 402 24 Göteborg
- Website:
- https://elicera.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Elicera Therapeutics AB develops immuno-oncology therapies based on CAR T-cell technology. They target various cancer indications.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Margareth Jorvid | Other | Other | 21,700 | 40,145.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GenSight Biologics S.A. | France | SIGHT | |
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO |